Literature DB >> 8747734

Epidemiological survey of burns treated in Ankara, Turkey and desirable burn-prevention strategies.

M Haberal1, N Uçar, N Bilgin.   

Abstract

From 1 January 1979 to 31 December 1993, 1109 patients were admitted to our burn unit located at Hacettepe University. Of the patients, 638 (57.5 per cent) were children (under the age of 16 years). The male to female ratio was 1.4:1 in children, and was approximately 2.6:1 for patients over 16 years of age. Of the 638 paediatric patients, 67 (10.5 per cent) sustained electrical burns. The causes of injury in the remaining 571 cases (89.5 per cent) were hot liquids in 379 (66.4 per cent of the non-electrical burns), flame in 190 (33.3 per cent) and contact burns in two (0.3 per cent). Of the scalds, 296 (78.1 per cent of the scalds), 52 (13.7 per cent), 22 (5.8 per cent) and nine (2.4 per cent) were caused by hot water, milk, meal and oil respectively. Of the flame burns, 21 (11.1 per cent) were due to LPG explosions. Of the 471 adult patients (over 16 years), 159 (33.8 per cent) were injured by electricity. The causes of non-electrical burn injuries were: hot liquid in 25, flame in 274, chemical agents in four, contact in four, and other causes in four. Although our centre is located in Central Anatolia, 41.8 per cent of all patients were referred from the other six regions of Turkey. Of the 1109 inpatients, 645 (58.2 per cent) were injured in Central Anatolia, 279 (25.2 per cent) in the Black Sea Region, 55 (5.0 per cent) in the Mediterranean Region, 18 (1.6 per cent) in the Marmara Region, 34 (3.1 per cent) in the Aegean Region, 52 (4.7 per cent) in Southeastern Anatolia and 26 (2.3 per cent) in Eastern Anatolia. Approximately two-thirds of the patients (419) required one or more surgical interventions, including debridement and grafting, as well as amputation. The most important early complications were acute renal failure (148 patients - 13.3 per cent), sepsis (660 patients - 59.5 per cent) and gastrointestinal haemorrhage (seven patients - 0.6 per cent). The overall mortality rate was 34.4 per cent. The epidemiological pattern of the burns showed that emergency measures should be taken to prevent scalding accidents to children throughout the country, and for electrical burns in adults, particularly those living in the Black Sea Region. In establishing, implementing and directing prevention programmes, regional differences should be taken into consideration.

Entities:  

Mesh:

Year:  1995        PMID: 8747734     DOI: 10.1016/0305-4179(95)00044-c

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  6 in total

1.  Pattern of high voltage electrical injuries in the Kashmir valley: a 10-year single centre experience.

Authors:  R A Kasana; P U F Baba; A H Wani
Journal:  Ann Burns Fire Disasters       Date:  2016-12-31

2.  Epidemiological data, outcome, and costs of burn patients in Kermanshah.

Authors:  B Karami Matin; R Karami Matin; T Ahmadi Joybari; N Ghahvehei; M Haghi; M Ahmadi; S Rezaei
Journal:  Ann Burns Fire Disasters       Date:  2012-12-31

3.  Shivlilik burns: injuries resulting from traditional celebrations.

Authors:  Metin Gündüz; İlhan Çiftçi; Tamer Sekmenli
Journal:  Int J Burns Trauma       Date:  2015-10-12

4.  Clinical and demographic features of pediatric burns in the eastern provinces of Turkey.

Authors:  Albayrak Yavuz; Albayrak Ayse; Yıldız Abdullah; Aylu Belkiz
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-01-18       Impact factor: 2.953

5.  Independent Predictive Factors of Hospitalization in a North-West Burn Center of Iran; an Epidemiologic Study.

Authors:  Samad Shams Vahdati; Bita Hazhir Karzar; Negar Momen
Journal:  Emerg (Tehran)       Date:  2015

6.  Epidemiology, Geographical Distribution, and Outcome Analysis of Patients with Electrical Burns Referred to Shiraz Burn Center, Shiraz, Iran during 2008-2019.

Authors:  Abdolkhalegh Keshavarzi; Zahra Rahgozar; Mojtaba Mortazavi; Ali Dehghani
Journal:  World J Plast Surg       Date:  2022-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.